Ascend Capital’s Constellium CSTM Stock Holding History

Ascend Capital’s Portfolio CSTM Stock Details CSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$11.6M	Sell	942,173 -30,113	-3%	-$352K	0.58%	61
2018 Q2	$10M	Sell	972,286 -64,952	-6%	-$755K	0.47%	70
2018 Q1	$11.3M	Sell	1,037,238 -257,586	-20%	-$3.14M	0.46%	78
2017 Q4	$14.4M	Buy	1,294,824 +75,362	+6%	+$802K	0.54%	60
2017 Q3	$12.5M	Buy	1,219,462 +305,790	+33%	+$2.9M	0.47%	69
2017 Q2	$6.3M	Buy	913,672 +277,820	+44%	+$1.81M	0.29%	95
2017 Q1	$4.13M	Buy	+635,852	New	+$4.54M	0.19%	105
2015 Q1	–	Sell	-301,281	Closed	-$4.95M	–	179
2014 Q4	$4.95M	Buy	+301,281	New	+$5.61M	0.19%	125

Other funds holding CSTM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BGIM

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Ascend Capital's CSTM Position: Q3 2018 in Review

Ascend Capital reduced its Constellium (CSTM) stake by 3.1% in Q3 2018, selling an estimated $352K and leaving 942,173 shares worth $11.6M. The position accounts for 0.58% of the portfolio, ranked #61.

Ascend Capital first reported a position in CSTM in Q4 2014 and has held it in 8 quarters since. The position peaked at $14.4M in Q4 2017. 143 funds tracked by Wall St. Rank hold CSTM as of Q3 2018.

Ascend Capital held 942,173 shares of Constellium worth $11.6M as of Q3 2018.
Ascend Capital sold 30,113 Constellium shares in Q3 2018, an estimated $352K.
Constellium made up 0.58% of Ascend Capital's portfolio in Q3 2018, its #61 holding.
Ascend Capital first reported a position in Constellium in Q4 2014 and has held it in 8 quarters since.
Ascend Capital's Constellium position peaked at $14.4M in Q4 2017.
143 funds tracked by Wall St. Rank held Constellium as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.